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In this study, the effect of surface nanoscale roughness on fibrinogen adsorption and platelet
adhesion was investigated. Nanorough silica surfaces with a low level of surface roughness (10 nm
Rrms) were found to support the same level of fibrinogen adsorption as the planar silica surfaces,
while nanorough silica surfaces with higher levels of surface roughness (15 nm Rrms) were found to
support significantly less fibrinogen adsorption. All surfaces analyzed were found to support the
same level of platelet adhesion; however, platelets were rounded in morphology on the nanorough
silica surfaces while platelets were spread with a well-developed actin cytoskeleton on the planar
silica. Unique quartz crystal microbalance with dissipation monitoring (QCM-D) responses was
observed for the interactions between platelets and each of the surfaces. The QCM-D data indicated
that platelets were more weakly attached to the nanorough silica surfaces compared with the planar
silica. These data support the role of surface nanotopography in directing platelet–surface interac-
tions even when the adsorbed fibrinogen layer is able to support the same level of platelet adhesion.
VC 2014 American Vacuum Society. [http://dx.doi.org/10.1116/1.4900993]
I. INTRODUCTION
Blood interactions with biomaterial surfaces are initiated
by protein adsorption, which influences subsequent blood
cell interactions with materials and ultimately the hemo-
compatibility of materials. Insights into the role of surface
properties in regulating protein adsorption and subsequent
platelet receptor binding events are crucial to develop
advanced materials capable of modulating platelet adhesion
and activation events at the blood–material interface and
hence long term function. Surface properties including
topography and chemistry are known to influence the extent
of protein adsorption, which proteins adsorb and their
conformation.1,2 Studies have shown that the surface topog-
raphy of an underlying substrate influences protein adsorp-
tion that precedes cell behavior such as adhesion,
orientation, and proliferation.3 Nanoscale surface topogra-
phy has previously been shown to alter adsorbed protein
conformation compared to planar surfaces;4–7 however, the
extent of conformational change is dependent on both the
surface nanofeatures and the protein under investigation.
Researchers have focused on the effect of ordered nano-
structures on protein adsorption including grooves8 and
pits,9 while other groups have investigated the effect of
stochastically rough surfaces,4–6,10 although each differ in
their reported effect due to the different surface topogra-
phies investigated.
Fibrinogen is one of the most abundant soluble extracel-
lular matrix proteins present in blood and likely to adsorb
to most surfaces.11–14 Fibrinogen and other serum proteins,
such as fibronectin and von Willebrand factor, mediate pla-
telet adhesion and aggregation via direct interaction with
platelet receptors.15–17 Surface bound fibrinogen has been
implicated in mediating the adhesion of platelets to syn-
thetic surfaces through the integrin aIIbb3.11 Platelet adhe-
sion to fibrinogen via aIIbb3 integrin involves the RGDS
site on the Aa chain and a non-RGD dodecapeptide
sequence in the c chain on fibrinogen.18 The few reports
describing the effect of surface nanotopography on platelet
adhesion indicate that this phenomenon is surface depend-
ent. Platelet adhesion to nanorough titanium surfaces has
been shown to be enhanced when precoated with fibrino-
gen.9 In contrast, vertically aligned multiwall carbon nano-
tubes resist platelet adhesion,19 and nanostructured
poly(ethylene oxide) had no effect on platelet adhesion
compared to planar controls.20 Recently, surface features in
the order of several hundred nanometers with low aspect
ratios have been found to experience lower fibrinogen
adsorption and platelet adhesion compared to their high
aspect ratio counterparts.7a)Electronic mail: m.lord@unsw.edu.au
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In this study, the adsorption and conformation of a
strongly anisotropic protein, fibrinogen, on stochastically
nanorough silica surfaces, with varying surface roughness,
and subsequent platelet interactions were investigated. The
aim of this study was to further elucidate the effect of sur-
face nanotopography on these interactions.
II. EXPERIMENT
Chemicals were purchased from Sigma-Aldrich (Castle
Hill, Australia) unless stated otherwise.
A. Surface fabrication
Gold quartz crystal microbalance (QCM) crystals
(QSX301, Q-Sense AB, Sweden) were covered with 0.32 g/l
aqueous dispersion of polycationic polymer, ZetagTM (Ciba
Specialty Chemicals Ltd., UK), a highly cross-linked copol-
ymer of acrylamide (20%) and quaternary dimethylaminoe-
thylacrylate (80%), for 10 min before rinsing with MilliQ
water for 3 min and dried with nitrogen. The polycationic
polymer was used to immobilize the silica nanoparticles
onto the gold surface and generate the nanorough silica
surfaces. The polymer-coated surfaces were covered with
30% w/v aqueous colloidal silica sols (W.R. Grace & Co.,
UK) for 5 min to ensure attachment of the silica particles to
the cationic polymer. Three types of silica sols were used
with average particle diameters of 7, 14, and 21 nm (Ludox
SM-30, HS-40, and TM-50, respectively). Substrates were
again rinsed with MilliQ water for 3 min and dried with
nitrogen. The silica-coated surfaces were then stored in a
desiccator for at least 24 h before use. SiO2 coated gold
(QSX303) QCM crystals (Q-Sense AB, Sweden) were used
as planar silica.
1. Surface characterization
Surface topography was analyzed by atomic force mi-
croscopy (AFM) in tapping mode using the BioScope
Catalyst AFM in air at a scan rate of 0.2 Hz and an aspect
ratio of 1. Scan sizes of 1 lm were obtained using a 2 nm
“ScanAsystAirþ” AFM tip (Bruker, Australia). Three sepa-
rate images were obtained for each sample and root-mean-
square (rms) surface roughness (Rrms) was calculated. A
Perkin Elmer Spotlight 400 Attenuated total reflectance-
Fourier transform infrared spectroscopy (ATR-FTIR) was
used to measure the surface chemical structure of the silica
surfaces with a penetration depth of 500 nm. Spectra were
recorded between 650 and 3500 cm1.
B. Quantification of protein adsorption
Single protein solutions of human fibrinogen (30 lg/ml)
and bovine serum albumin (BSA, 30 lg/ml) were prepared
in phosphate buffered saline (PBS), pH 7.4. Human plasma
(10% v/v) in PBS was used as the complex protein solution.
Quantification of protein adsorption was carried out using
a quartz crystal microbalance with dissipation monitoring
(QCM-D, D300 model, Q-Sense AB, Sweden) in static
mode at 376 0.1 C. Surfaces were exposed to PBS and sta-
ble frequency (f) and dissipation (D) measurements estab-
lished. Test protein solutions were exposed to the surfaces
for 60 min and then rinsed with PBS until consistent f and D
measurements were obtained. A minimum of three adsorp-
tion curves were recorded for each material for all test pro-
teins, which were measured at the fundamental f (5 MHz)
as well as the third (15 MHz), fifth (25 MHz), and seventh
(35 MHz) overtones. All solutions were passed through a
0.22 lm filter and degassed at room temperature before use.
Adsorbed mass estimates were obtained using the Voigt
model and adjusted for the surface area measured by AFM.
Surfaces coated with fibrinogen were additionally treated
with 0.1% (w/v) casein to block remaining surface binding
sites for 30 min, rinsed with PBS until consistent f and D
measurements were obtained, incubated with an antifibrino-
gen antibody (5 lg/ml, clone 2C2-G7, IgG, Bio-Scientific
Pty. Ltd., Gymea, Australia) prepared in 0.1% (w/v) casein
for 30 min and rinsed with PBS until consistent f and D
measurements were obtained. Adsorbed antibody mass esti-
mates were also obtained using the Voigt model. Control
experiments were performed for nonspecific antibody bind-
ing to the fibrinogen coated surfaces with an antialbumin
antibody (5 lg/ml, clone HSA-11, IgG, Sigma Aldrich,
Castle Hill, Australia). The epitope for the antifibrinogen
antibody, clone 2C2-G7, is able to recognize or sterically
hinder regions of fibrinogen important for platelet
aggregation.
Fibrinogen adsorption to the surfaces was also measured
using biotinylated fibrinogen. 10mM EZ-link NHS-Biotin
(Pierce Biotechnology, Australia) diluted in dimethylsulfox-
ide was added to 5 mg/ml fibrinogen in PBS and incubated
in the dark for 2 h before separating the biotinylated proteins
from excess biotin using a 10 kDa microcon (BD, Australia)
centrifuged at 13 000 rpm for 15 min. Following a washing
step with PBS, the solution was centrifuged for 15 min and
washed six times before use. The final concentration of pro-
tein was measured using the Coomassie Blue Protein Assay
(Pierce Biotechnology, Australia). Biotinylated fibrinogen
was diluted to 30 lg/ml and exposed to the surfaces for 60
min followed by rinsing with PBS. The surfaces were then
blocked with 0.1% (w/v) casein for 30 min and rinsed with
PBS. The bound biotinylated fibrinogen was detected with
streptavidin-horseradish peroxidase (SA-HRP,GE
Biosciences, Sydney, Australia, 1:500) for 30 min at 25 C
using 2mM 2,20-azino-di-3-ethylbenzthiazoline sulfonic
acid and H2O2 as chromogen in 50mM sodium citrate, pH
4.6. Absorbance values were measured at 405 nm.
C. Platelet isolation from human blood
Platelets were harvested from human donors under ethics
approval from the University of New South Wales. Blood
was collected in acid citrate dextrose anticoagulant treated
vacutainers. Platelet rich plasma was prepared by centrifuga-
tion of the blood at 350 g for 20 min at room temperature
followed by careful removal of the upper platelet-rich layer.
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Platelet rich plasma was then centrifuged at 1200 g for
10min to yield a platelet pellet with platelet poor plasma as
the supernatant. The platelet pellet was resuspended in
Tyrode’s buffer (1.8mM CaCl2, 1mM MgCl2, 2.7mM KCl,
136.9mM NaCl, 0.4mM NaH2PO4, 11.9mM NaHCO3, and
5.6mM D-glucose) containing 0.1 U/ml apyrase and centri-
fuged again at 1200 g for 10 min. The supernatant was dis-
carded and the platelets resuspended in Tyrode’s buffer,
containing 0.1 U/ml apyrase, to a concentration of 2 107
platelets/ml based on haemocytometer counts.
D. Platelet adhesion assays
1. Lactate dehydrogenase assay
Quantification of platelets adhered to test surfaces was
determined using an in vitro using a lactate dehydrogenase
assay (LDH, TOX7 kit).21 This method is based on the reduc-
tion of NAD by the action of LDH, which is a stable cytoplas-
mic enzyme present in cells. It is rapidly released into the
lysing solution upon damage of the plasma membrane. The
use of a toxicology assay kit allows quantification of the num-
ber of platelets as a function of the amount of LDH released.
Surfaces were exposed to BSA (30 lg/ml), human fibrino-
gen (30 lg/ml), or 10% (v/v) human plasma for 1 h at 37 C.
All protein solutions were diluted in PBS. Wells were then
blocked with 0.1% (w/v) BSA in PBS for 2 h at 37 C to coat
the remaining surface binding sites. Platelets (1 ml of 2 107
platelets/ml) were incubated on the surfaces for 1 h at 37 C.
Test surfaces were rinsed twice with PBS (prewarmed
37 C). Platelet suspension (2 107 platelets/ml in Tyrodes
buffer containing Apyrase) was added to each well and incu-
bated for 1 h. The platelet suspension was then removed from
the wells and test surfaces were washed six times with PBS.
Surfaces were moved to fresh wells to eliminate counting pla-
telets adhered to the wells and a 1/10 lysis solution in PBS
was added to each well and incubated at 37 C for 45 min to
lyse the adhered platelets. A standard curve was generated in
parallel using platelet concentrations in the range of
2 104–2 107 platelets/ml. Equal volumes of platelet
lysates (50 ll) and LDH solution (50 ll) were transferred to
wells of a TCPS 96—well plate and incubated for 30 min at
37 C. The absorbance was measured at 490 nm against a
650 nm reference using a microplate reader.
2. Fluorescence microscopy
Imaging of the actin cytoskeleton of platelets on the vari-
ous surfaces was performed as described previously.22
Surfaces were exposed to BSA (30 lg/ml), human fibrinogen
(30 lg/ml) or 10% (v/v) human plasma for 1 h at 37 C. All
protein solutions were diluted in PBS. Wells were then
blocked with 0.1% (w/v) BSA in PBS for 2 h at 37 C to coat
the remaining surface binding sites. Selected samples
were subsequently incubated with antifibrinogen antibody
(5lg/ml, clone 2C2-G7) diluted in 0.1% (w/v) BSA in PBS
for 1 h at 37 C and then rinsed with PBS. Wells were then
blocked with 0.1% (w/v) BSA in PBS for 2 h at 37 C.
Platelets (1 ml of 2 107 platelets/ml in Tyrodes buffer
containing Apyrase) were incubated on the surfaces for 1 h at
37 C, either alone or in combination with antihuman GP
IIb-IIIa receptor (integrin aIIbb3) F(ab) fragment antibody
(1lg/ml, Abciximab, Eli Lily, Sydney, Australia). Platelets
were fixed with 4% (w/v) formaldehyde and 1% (w/v) su-
crose in PBS for 20 min at 37 C followed by permeabiliza-
tion for 5 min at 4 C with 0.3 M sucrose, 0.05 M NaCl,
3mM MgCl2, 0.2 M HEPES, 0.5% (w/v) Triton X-100, pH
7.2. Wells were then blocked with 1% (w/v) BSA in PBS for
5 min at 37 C followed by incubation with rhodamine-
phalloidin (1:100 in 1% (w/v) BSA in PBS, Life
Technologies, Sydney, Australia) for 1 h at 37 C. Samples
were then washed twice with 0.5% (w/v) Tween-20 in PBS
before imaging using a fluorescence microscope (Zeiss,
Sydney, Australia). Quantitative analysis of the fluorescence
microscope images was performed using a pixelated com-
puter program (NIH ImageJ) to determine the number of
adhered platelets for each condition.
3. Quartz crystal microbalance assays
Platelet interactions with protein coated surfaces were meas-
ured in a quartz crystal microbalance with dissipation monitor-
ing (QCM-D) window chamber (QWiC 301, Q-Sense AB,
Sweden) which was internally maintained at 37.06 0.1 C
under static conditions. Planar silica or colloidal silica coated
QCM crystals were mounted in the window chamber. PBS was
injected into the chamber and allowed to stabilize before being
removed and replaced with a solution in PBS of either bovine
serum albumin (30 lg/ml), fibrinogen (30 lg/ml) or 10% (v/v)
human plasma which was allowed to adsorb for 1 h. The cham-
ber was then rinsed with PBS, allowing for f and D stabiliza-
tion. PBS was replaced with 0.1% (w/v) BSA in PBS and
allowed to stabilize for 30 min before being replaced with 1 ml
of platelet suspension containing 2 107 platelets/ml in
Tyrode’s buffer containing 0.1 U/ml apyrase. Platelet interac-
tions with the protein coatings were monitored for 1 h after an
initial thermal settling period of 10 min. Additionally, selected
protein coatings were exposed to platelets in the presence of
anti-aIIbb3 (2.5 lg/ml) Fab fragment antibody. It is important
to note that the Fab fragment antibodies do not support platelet
aggregation, which would confound the results. Experiments
were performed in triplicate with representative profiles pre-
sented. Platelet interaction measurements are presented as Df
plots and were fitted to the Voigt model.
E. Statistical analysis
A two-way analysis of variance (ANOVA) was per-
formed to compare multiple conditions. Results of p< 0.05
were considered significant. Experiments were performed in
triplicate and were repeated twice.
III. RESULTS AND DISCUSSION
A. Surface characterization
Surfaces were characterized by AFM in tapping mode to
measure the root mean square surface roughness (Rrms)
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(Table I). The planar silica coated QCM-D crystals were
found to have an Rrms of 2.386 0.80 nm while the surfaces
generated using the 7, 14, and 21 nm silica nanoparticles
exhibited a size-dependent increase in Ra of 9.886 2.42,
10.766 2.62, and 15.286 1.71 nm, respectively. The surfa-
ces that were generated using the silica nanoparticles exhib-
ited a uniform surface topography [Fig. 1(a)] with a
stochastic surface roughness as previously reported and
nanoparticles that completely covered the polycationic
layer.1 The planar silica surface was smooth with very few
topographical features [Fig. 1(b)]. The corresponding
increase in surface area for the surfaces generated using the
7, 14, and 21 nm silica nanoparticles resulted in an increase
in surface area compared to the planar silica of 126 5%,
156 6%, and 276 5%, respectively (Table I).
ATR-FTIR confirmed the presence of SiO2 with bands
between 800 and 1260 cm1 ascribed to the superposition of
various SiO2 peaks including asymmetric vibration of Si-O
(1090 cm1) and symmetric vibration of Si-O (795 cm1)
[Fig. 1(c)]. These peaks were present in the planar silica as
well as the 7, 14, and 21 nm silica nanoparticles with no
appreciable difference in intensity indicating that the surface
chemistry of each of the silica surfaces was similar.
B. Protein adsorption and conformation
Fibrinogen adsorption onto each of the silica surfaces was
investigated in real time using QCM-D (Fig. 2). Changes in
frequency (Df) and dissipation (DD) measured by the QCM-
D were monitored over a period of 60 min exposure time to
the fibrinogen and subsequent PBS rinses [Fig. 2(a)]. The Df
values observed for fibrinogen adsorption onto each of the
surfaces were similar throughout the measurement period
while different DD values were observed. Fibrinogen bound
to the nanorough silica surfaces exhibited smaller DD values
than fibrinogen bound to the planar silica. Adsorption of
fibrinogen onto each of the surfaces resulted in little change
in f measurements after PBS rinses for each of the surfaces
indicating that the adsorption may be largely irreversible or
that desorption was very slow. Changes in Df and DD were
used to estimate the mass of irreversibly adsorbed fibrinogen
onto each of the surfaces. The Voigt model was used to esti-
mate the mass of adsorbed fibrinogen as fibrinogen
adsorption onto all of the surfaces under investigation was
found to yield DD values for all overtones greater than
1 106, while very limited f dependency was observed.
Mass values derived from the Voigt model were adjusted for
changes in surface area due to the surface roughness. There
was significantly less fibrinogen adsorbed onto the 21 nm
silica surface compared to the planar silica (p< 0.05), while
there was no significant difference in the amount of fibrino-
gen bound to either the 7 or 14 nm silica surfaces or the
Zetag surface compared to the planar silica [Fig. 2(b)].
Fibrinogen adsorption onto nanorough tantalum surfaces has
previously been reported to increase with increasing surface
roughness23 to a larger extent than the corresponding
increase in surface area. This was attributed to the whisker-
like protrusions deposited by the glancing angle deposition
(GLAD) technique that created the nanorough surface
TABLE I. Surface roughness of substrates characterized by AFM and the
increase in surface area compared to planar SiO2 coated QCM crystals. Data
presented as mean 6 standard deviation (n¼ 3). * indicates significant dif-
ference (p< 0.05) compared to planar silica and ** indicates significant dif-





Increase in surface area
compared to planar silica
coated QCM crystals (%)
Planar silica 2.386 0.80** —
7 nm silica 9.886 2.42* 126 5*
14 nm silica 10.766 2.62*, ** 156 6*
21 nm silica 15.286 1.71*, ** 276 5*, **
Zetag 1.926 0.59** —
FIG. 1. AFM images of (a) 21 nm silica and (b) planar silica with a scan size
of 1 1 lm2 and a vertical range of 100 nm. (c) ATR-FTIR spectra of planar
silica as well as 7, 14, and 21 nm silica surfaces.
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topography. These surface nanofeatures were hypothesized
to lead to fibrinogen being adsorbed in a predominantly end-
on configuration, which led to a more closely packed protein
layer. This same observation has been reported for platinum
surfaces with nanorough surface topography that was also
generated by the GLAD technique.24 These studies investi-
gated nanoscale surface roughnesses in the order of the Rrms
values of 2–32 nm for the tantalum surfaces and 1.5–9 nm
for the platinum surfaces. These are in the same order of
magnitude as the roughness of the silica surfaces analyzed in
the present study; however, the nanotopography profile was
quite different for the nanorough surfaces generated using
GLAD compared to the silica particle deposition technique
used in this study. This indicated that surface topography,
not just overall surface roughness, may explain the different
fibrinogen binding mechanism observed in this study.
QCM-D measurements include water bound and/or
hydrodynamically coupled to the adsorbed proteins. The dif-
ference between adsorbed fibrinogen mass estimates for
QCM-D measurements and optical techniques, such as
ellipsometry and optical waveguide lightmode spectroscopy,
previously reported indicated that QCM-D measurements
are a factor of between 2.8 and 3.2 larger than the optical
techniques.25 The theoretical side-on monolayer coverage of
fibrinogen is approximately 140 ng/cm2 while the close
packed end-on monolayer is 1000 ng/cm2 (Ref. 25), which
equates to approximately 420 and 3000 ng/cm2, respectively,
for QCM-D measurements. The experimentally determined
adsorbed fibrinogen estimates [Fig. 2(b)] indicated that fibri-
nogen was bound to all the surfaces in the range of
1500–2000 ng/cm2, consistent with fibrinogen adsorbed onto
each of the surfaces in a mixture of end-on and side-on
FIG. 2. (a) Comparison of fibrinogen adsorption profiles determined by QCM-D as monitored by D f3/3 and DD3; (b) mass adsorption of fibrinogen onto each
of the surfaces as determined by Voigt modeling of QCM-D data and adjusted for surface area as determined by AFM; (c) relative amount of biotinylated fibri-
nogen bound to each of the nanorough silica surfaces compared to planar silica adjusted for surface area as determined by AFM; (d) dissipation vs frequency
ratio (DD/Df) of QCM-D data presented for the 3rd overtone; (e) mass of antibody adsorbed to each of the fibrinogen coated surfaces as determined by Voigt
modeling of the QCM-D data and adjusted for surface area as determined by AFM; and (f) moles of fibrinogen antibody bound per mole of fibrinogen on each
of the surfaces as determined by QCM-D. Error bars: SD (n¼ 3). * indicated significant differences (p< 0.05) compared to planar silica as determined by a
two-way ANOVA.
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configurations. The relative amount of fibrinogen bound to
each of the surfaces was analyzed by measuring the amount
of adsorbed biotinylated fibrinogen to each of the silica
surfaces and the values were adjusted for increased surface
area on the nanorough surfaces compared to the planar silica
[Fig. 2(c)]. There was significantly less fibrinogen adsorbed
onto the 21 nm silica surface compared to the planar silica
(p< 0.05), while there was no significant difference in the
amount of fibrinogen bound to either the 7 or 14 nm silica
surfaces compared to the planar silica, confirming the QCM-
D results shown in Fig. 2(b).
Analysis of the ratio between DD and Df has been shown
to provide a qualitative measure of the rigidity of protein
films26 and may infer structural changes in the protein layer
and/or the extent of hydrodynamically bound water.27,28
Stable DD/Df values after protein adsorption and PBS rinses
for the third overtone for fibrinogen adsorbed onto each of the
silica nanorough surfaces were lower compared to the planar
silica, which indicated that the fibrinogen formed a more rigid
layer on the nanorough surfaces compared to planar silica
[Fig. 2(d)]. There was no significant difference between the
DD/Df values for the Zetag coated surface and planar silica
[Fig. 2(d)]. The difference in DD/Df values for the nanorough
surfaces and the planar silica was primarily due to the larger
DD values observed for fibrinogen adsorption on the planar
silica with DD of 1 106 for fibrinogen adsorbed onto
21 nm nanorough silica. Surfaces that are rough can entrap
liquid within surface cavities29,30 and have been shown to
result in an excess liquid phase response in the QCM-D, pri-
marily observed as a larger magnitude decrease in f (Ref. 31)
FIG. 3. Platelet adhesion to fibrinogen, plasma, or albumin coated planar silica, nanorough silica, or Zetag coated surfaces determined by (a) LDH assay and
(b) analysis of fluorescence microscope images of platelets exposed to protein coated surfaces and stained for the presence of actin. Data presented have been
corrected for changes in surface area induced by the surface coatings. Error bars: SD (n¼ 3). * indicated significant differences (p< 0.05) compared to
untreated planar silica and ** indicated significant differences (p< 0.05) compared to untreated 21 nm silica as determined by a two-way ANOVA.
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accompanied by little change in D compared with smooth
surfaces. The liquid “trapped” within the surface structure can
be treated as a rigid mass as long as the lateral scale of the
surface roughness is less than the penetration depth.32 This
phenomenon would result in smaller DD/Df values for rough
surfaces compared to the planar silica. Although smaller DD/
Df values were observed in this study for the nanorough surfa-
ces compared to the planar silica, larger decreases in f were
not observed in this study for the nanorough surfaces com-
pared to the planar silica. This indicated that water trapped in
the surface features was not responsible for the stiffer protein
layers on the nanorough surfaces compared to the planar
silica, but likely to be changes in the orientation, conforma-
tion and/or hydration state of the proteins.
Structural changes in the fibrinogen adsorbed onto each
of the surfaces was also investigated using QCM-D by meas-
uring the amount of fibrinogen antibody that bound to the
fibrinogen adsorbed onto each of the surfaces and mass val-
ues were adjusted for the surface area as measured by AFM
[Fig. 2(e)]. The fibrinogen antibody used binds to the platelet
binding region of fibrinogen and hence was used to infer the
structure of the adsorbed fibrinogen and its capacity to sup-
port platelet binding to the different surfaces. Each of the
fibrinogen coated surfaces was found to support a similar
level of antibody binding [Fig. 2(e)]. Non-specific antibody
binding to the protein precoated surfaces was determined by
measuring both the binding of the fibrinogen antibody to
casein precoated surfaces and antialbumin antibody binding
to the fibrinogen coated surfaces using the QCM-D. A maxi-
mum of 22 ng/cm2 of antibody was detected, indicating a
low level of nonspecific antibody binding to the test surfaces.
The molar ratio of the adsorbed fibrinogen antibody to the
adsorbed fibrinogen for each of the surfaces indicated that
was no significant difference in the amount of antibody
bound to fibrinogen adsorbed onto the nanorough silica
surfaces and Zetag coated surface compared to planar silica
[Fig. 2(f)]. This provides an indication that surface topogra-
phy may not change the capacity of the adsorbed fibrinogen
to bind platelets on the different surfaces.
C. Platelet adhesion
Platelet adhesion to protein precoated nanorough silica
surfaces was investigated to determine whether stochastic sur-
face nanotopography affected the activity of the adsorbed pro-
teins. The number of platelets adhered to protein precoated
nanorough silica surfaces was not affected by the surface
nanotopography when compared to planar silica [Fig. 3(a)].
Albumin precoated surfaces supported less platelet adhesion
compared with fibrinogen or plasma precoated surfaces con-
firming previous reports that albumin minimizes platelet ad-
hesion.33 This phenomenon was also observed for albumin
coated nanorough surfaces, although the adhesion of platelets
to each of the albumin coated surfaces would indicate that al-
bumin does not completely inhibit platelet adhesion.
Albumin coated polystyrene has also been reported to
support nonspecific platelet adhesion.34 As each of the
nanorough silica surfaces supported the same level of plate-
let adhesion, only the 21 nm surface was taken forward for
further analysis. The number of platelets adhered to fibrino-
gen coated planar silica and 21 nm silica was significantly
(p< 0.05) inhibited by the addition of antibodies that bound
to either the platelet binding site on fibrinogen (clone 2C2-
G7) or antibodies that bound to the aIIbb3 integrin on the
surface of platelets [Fig. 3(b)]. Surface topography had no
effect on the number of platelets adhered to the different
fibrinogen precoated surfaces [Fig. 3(a)] supporting the find-
ing that although there was a reduced amount of fibrinogen
adsorbed to the 21 nm silica surface, there was no significant
difference in the amount of fibrinogen antibody that bound
to the fibrinogen adsorbed onto each of the surfaces [Fig.
2(d)]. These data suggested that the orientation and hydra-
tion of adsorbed fibrinogen on each of the surfaces had no
effect on the level of platelet adhesion.
Analysis of the morphology of platelets adhered to pro-
tein coated surfaces indicated that platelets adhered to fibri-
nogen coated planar silica with a spread morphology and
well-developed actin fibers at the leading edge of the cell
membrane [Fig. 4(a i)]. In contrast, platelets adhered to fibri-
nogen coated 21 nm silica surfaces exhibited a rounded
FIG. 4. Fluorescence microscope images of platelets exposed to (a) planar
silica or (b) 21 nm silica precoated with (i) fibrinogen, (ii) plasma, (iii) albu-
min, or (iv) fibrinogen when platelets were pretreated with anti-aIIbb3 integrin
antibody and stained for their actin cytoskeleton. Scale bar represents 2lm.
041002-7 Lord et al.: Fibrinogen adsorption and platelet adhesion to silica surfaces 041002-7
Biointerphases, Vol. 9, No. 4, December 2014
morphology with radial protrusions containing actin that was
not filamentous [Fig. 4(b i)]. Similarly, platelets adhered to
plasma coated 21 nm silica exhibited a rounded morphology
with radial protrusions containing actin that was not filamen-
tous [Fig. 4(b ii)] while platelets adhered to plasma coated
planar silica surfaces exhibited a more spread morphology
with radial protrusions [Fig. 4(a ii)]. Platelets adhered to al-
bumin coated surfaces exhibited a rounded morphology with
no apparent development of actin-rich stellate-shaped pseu-
dopodia [Figs. 4(a) and 4(b iii)] and this same morphology
was observed for platelets treated with anti-aIIbb3 Fab frag-
ment antibody and then exposed to fibrinogen coated surfa-
ces (Figs. 4(a) and 4(b iv)]. Hence, although the level of
platelet adhesion to the fibrinogen coated surfaces was the
same, there were differences in the morphology of the
attached platelets, indicating that surface nanotopography
altered the platelet responses.
The Df and DD versus time plots are shown for the albu-
min blocking step following fibrinogen adsorption onto the
surfaces and the platelet exposure step for planar silica
[Fig. 5(a)] and 21 nm silica [Fig. 5(b)]. The addition of albu-
min resulted in a decrease in f and an increase in D for each
of the surfaces. Exposure of platelets to albumin blocked
fibrinogen on the planar silica resulted in a further decrease
in f and increase in D with close agreement between the
third, fifth, and seventh overtones [Fig. 5(a)]. In contrast,
platelets exposed to fibrinogen coated and albumin blocked
21 nm silica surfaces resulted in little change in f over the
measurement period that was accompanied by increases in D
[Fig. 5(b)]. The DD values for the fifth and seventh over-
tones were in good agreement with slightly higher DD values
recorded for the third overtone.
Typical Df plot for platelets interacting with fibrinogen
surfaces are shown in Fig. 6(a) and the arrows indicate the
time sequence of the data. The QCM-D responses for plate-
lets adhering to fibrinogen coated planar silica and 21 nm
silica surfaces were quite different from each other which
indicated that platelets interacted differently with each of
these surfaces, even though they all supported the same level
of platelet adhesion [Figs. 3(a) and 3(b)]. The viscoelastic
region on the Df plot is the region between a pure elastic
mass response where DD¼ 0 and a pure liquid viscosity-
density change in the fluid above the crystal in the absence
of surface binding [Fig. 6(a)].29,35 Exposure of platelets to
planar silica coated with fibrinogen resulted in Df plots that
fell within the viscoelastic region and hence these interac-
tions behaved as viscoelastic materials during the first 30
min. During the last 30 min of the experiment the Df
responses deviated from the viscoelastic behavior as the pla-
telets exhibited a greater level of energy dissipation above
the sensor surface. The Df plots for platelets interacting with
fibrinogen coated planar silica continued to exhibit decreases
in f and increases in D throughout the measurement period
which was consistent with increased platelet surface contact
and hence increased platelet volume being sensed through-
out the measurement period. Coupled with this was the de-
velopment of the actin cytoskeleton as shown by the spread
morphology of platelets adhered to this surface [Fig. 4(a i)].
Hence, the deviation from viscoelastic behavior coincided
with actin polymerization to form actin-rich radial protru-
sions. This phenomenon has been observed previously for
many mammalian cells as active cell–surface contacts are
formed and their cytoskeleton develops within 1–15 min af-
ter attachment to a surface.29,35–38 Interestingly, platelets
exposed to fibrinogen coated planar silica did not cause any
change in D throughout the second 30 min of exposure, but
caused an increase in f. Positive f shifts have been reported
for colloidal particles that form point contacts with the reso-
nator surface and have a high mass.39 When the particles
only form point contacts with the resonator surface, the
forces exerted by the resonating crystal do not move the par-
ticles; however, the particles exert a restoring force on the
crystal which adds internal stiffness to the crystal, thereby
increasing f.40 Hence, changes in f depend on the coupling
strength, surface coverage, and inertial forces that are driven
FIG. 5. Dfn/n and DDn measurements vs time for (a) planar silica and (b) 21 nm
silica surfaces precoated with fibrinogen and exposed to albumin followed by
platelet suspension. The arrows indicate the time of addition of albumin and
platelets, respectively, while the surfaces were exposed to PBS prior to the
addition of albumin. Data presented for the third, fifth, and seventh overtones.
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by the properties of the adsorbed layer. The positive f shifts
observed in this study for platelets interacting with planar
silica are likely to be due to changes in the viscoelastic prop-
erties of the adhered platelet layer. Positive f shifts have
been reported when the ratio between viscosity and elasticity
of a cell layer increases.40,41 These mechanical changes in
the cell layer are largely driven by changes in the cytoskele-
ton and have been previously reported for fibroblast cells
interacting with serum coated oxidized polystyrene37 as well
as epithelial cells.42
The Df plot for platelets interacting with fibrinogen
coated 21 nm silica surfaces was quite different compared to
the Df plot for platelets interacting with planar silica [Fig.
6(a)]. After an initial decrease in f to 3Hz and an increase
in D to 4.5 106, there was little change in both f and D
throughout the measurement period. This indicated that there
was a low level of platelet–surface contact throughout the
measurement period that was consistent with the rounded
morphology of platelets exposed to this surface [Fig. 4(b i)].
Throughout the measurement period the platelet response to
this material fell outside the viscoelastic region with high D
values, almost no change in f and little change in these
measurements over the experimental period. High DD/Df
ratios have been observed when there is a weak coupling
between the resonator and the bound layer, which is indica-
tive that the platelets were loosely bound to the 21 nm silica
surface.43,44 This indicated that the contact strength between
platelets and fibrinogen coated surfaces was weaker for the
nanorough surfaces than the planar silica.
The response of platelets to each of the albumin coated
surfaces was also quite different and indicated that surface
topography played a role in the QCM responses [Fig. 6(b)].
The Df plot for platelets exposed to albumin coated surfaces
showed little change in measurements throughout the experi-
ment after the initial platelet–surface contact that resulted in
shifts in f approximately 5Hz each. The difference
between the platelets exposed to the different albumin coated
surfaces is evident in DD as platelets exposed to albumin
coated planar silica resulted in a maximum DD of 1.8 106
while platelets exposed to albumin coated 21 nm silica
resulted in a maximum DD of 3.7 106. Additionally, DD
has been reported to be considerably larger for loosely
adhered particles in contact with the resonator surface com-
pared to a homogeneous film with the same thickness and
viscoelastic properties.40 Hence, DD/Df increases with
weaker contacts between the platelets and the protein coated
surfaces as observed in this study for the 21 nm silica surfa-
ces which supported weaker platelet–surface point contacts
than planar silica, irrespective of adsorbed proteins.
Preincubation of the platelets with anti-aIIbb3 antibody
followed by exposure to fibrinogen coated surfaces presented
Df responses that fell within the viscoelastic region for pla-
nar silica [Fig. 6(c)]. Platelets exposed to fibrinogen coated
planar silica displayed decreases in f and increases in D
throughout the measurement period, that closely followed
the viscosity–density relationship between DD and Df. The
response of platelets preincubated with anti-aIIbb3 antibod-
ies and exposed to fibrinogen coated planar silica resulted in
final DD and Df values of 1 106 and 8Hz, respectively,
indicating that only low levels of platelet cell membrane
focal contacts were coupled to the resonator surface at the
end of the measurement period. Similarly, platelets treated
with anti-aIIbb3 antibodies exposed to 21 nm silica surfaces
caused decreases in f and increases in D [Fig. 6(c)] through-
out the measurement period that closely followed the visco-
sity–density relationship with final DD and Df values of
2.2 106 and 10Hz, respectively. Platelet interactions
with surfaces analyzed by the QCM-D are not limited to irre-
versible platelet adhesion as transient platelet contacts are
recorded and indicate that platelet–surface contact can occur
even in the presence of anti-aIIbb3 which does not allow the
development of stable platelet–surface contacts such as
integrin mediated adhesion.
Analysis of the Df and DD responses from platelet inter-
actions with fibrinogen coated surfaces cannot be interpreted
by the Sauerbrey relationship due to the high D values
obtained. The Voigt model assumes that the adsorbed layer
is of uniform thickness and density, conserves its shape and
does not flow.45 While this model has limitations for
FIG. 6. Df plots for platelets exposed to (a) fibrinogen coated planar silica
and 21 nm silica, (b) albumin coated planar silica and 21 nm silica, or (c)
platelets preincubated with anti-aIIbb3 antibody and then exposed to fibri-
nogen coated planar silica and 21 nm silica monitored over a period of 1 h
at 37 C. The arrows indicate the time course of the data points. The pure
elastic mass and viscosity–density responses are indicated by the dashed
lines.
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modeling platelet–surface interactions as the platelet layers
observed in this study are heterogeneous, this model pro-
vided a good fit for the data obtained for platelets interacting
with fibrinogen coated planar silica [Fig. 7(a)]. There is
good agreement in the raw and fitted values between over-
tones for platelet interactions with fibrinogen coated planar
silica indicating homogeneity in the platelet–surface interac-
tions across the resonator surface for these coatings. Raw
data for platelets exposed to fibrinogen coated 21 nm silica
surfaces showed variation between the scaled overtones in
the DD values with the third overtone exhibiting higher val-
ues than the fifth and seventh overtones, which indicated het-
erogeneity in the platelet–surface interactions across the
resonator surface [Figs. 5(b) and 7(b)]. The Voigt model pro-
vided a fit of the raw data and also displayed heterogeneity
in the DD values (Fig. 7). The Voigt model fit for the mass
of platelets bound to fibrinogen coated planar silica was
approximately 41 lg/cm2. Using the platelet density and vol-
ume as 1.0712 g/cm3 and 7 1012 cm3, respectively,
approximately 2.3 107 platelets in a spherical morphology
can completely cover the surface of a QCM crystal, which
equates to approximately 1.7 105 ng/cm2. Approximately
26% of the surface area of fibrinogen coated planar silica
was calculated to be covered by platelets from the Voigt
model, which is in close agreement with 326 6% of the sur-
face covered by platelets as determined by analysis of fluo-
rescence microscope images of actin stained platelets. The
Voigt model, however, overestimated the proportion of the
surface covered by platelets on fibrinogen coated 21 nm
silica at approximately 20% while image analysis indicated
that 106 3% of the surface was covered by platelets. This
discrepancy could be due to the QCM-D measuring transient
cell–surface interactions that were not observed after fixation
and imaging of the platelets. Together these data further sup-
ported that platelet adhesion was altered on the 21 nm silica
surface compared to the planar silica.
IV. SUMMARYAND CONCLUSIONS
The present study has shown that stochastically nano-
rough silica surfaces were able to support the same level of
fibrinogen adsorption, except for the roughest surface ana-
lyzed with a Rrms of 15 nm, which supported significantly
less fibrinogen adsorption, compared to planar silica.
Fibrinogen was found to adsorb in a more rigid layer on all
the nanorough surfaces compared to the planar silica; how-
ever, all surfaces supported the same level of platelet adhe-
sion. Platelets bound to fibrinogen coated nanorough silica
surfaces were rounded in morphology with few actin-rich ra-
dial protrusions while platelets bound to planar silica were
spread with a well-developed actin cytoskeleton. QCM-D
analysis indicated that platelets were more loosely adhered
to the nanorough surfaces compared to the planar silica.
Unique QCM-D responses were found for platelets exposed
to each of the protein coated surfaces and indicated that the
interactions are unique for each cell adhesive protein and
surface. The Voigt model provided a realistic fit of the
QCM-D data that correlated well with the microscopy
images of adhered platelets. Together these data provide
additional information about the dynamics of platelet–bio-
material interactions and demonstrate that surface nanoto-
pography can affect cell–surface interactions that may have
application in understanding platelet–material interactions
for the development of blood contacting devices.
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